نتایج جستجو برای: Botulinum Neurotoxin Type E

تعداد نتایج: 2292084  

Background and Objectives: Botulism syndrome is caused by one of the seven botulinum neurotoxins. The toxins binding domain have immunogenicity effect and can be used as a recombinant vaccine candidate against botulism disease. Due to the low immunogenicity of recombinant protein , the use of an appropriate vehicle for antigen delivery to target cells is inevitable. The purpose of this study ...

Journal: :molecular biology research communications 2013
seyed jafar mousavy mosayeb rostamian firouz ebrahimi mohammad reza dayer

recombinant proteins are tending to be the most favorable vaccine-candidates against botulism. recombinant carboxy-terminal of botulinum neurotoxin serotype e (rbont/e-hcc) has been introduced as an efficient vaccine against botulism type e. in this report, we made an effort to investigate the effect of different ph on protein structure to assess if rbont/e-hcc could be used as a vaccine for or...

2013
Andrew T. Carter Sandra C. Stringer Martin D. Webb Michael W. Peck

Genome sequences of five different Group II (nonproteolytic) Clostridium botulinum type F6 strains were compared at a 50-kb locus containing the neurotoxin gene cluster. A clonal origin for these strains is indicated by the fact that sequences were identical except for strain Eklund 202F, with 10 single-nucleotide polymorphisms and a 15-bp deletion. The essential topB gene encoding topoisomeras...

ابراهیمی, فیروز , باقری پور, محمدجواد, حاجی زاده, عباس, نظریان, شهرام,

Abstract Background and purpose: Clostridium botulinum neurotoxins are the most potent toxins that cause the life-threatening botulism syndrome in humans and animals. Researches have shown that the binding domain of the botulinum neurotoxin type E has a high immunogenicity effect that could be used as an efficient recombinant vaccine. The recombinant vaccines are not potent enough to stimulate...

Journal: :iranian biomedical journal 0
مصیب رستمیان mosayeb rostamian سید جعفر موسوی seyed jafar mousavy فیروز ابراهیمی firouz ebrahimi سید ابوالقاسم قدمی seyyed abolghasem ghadami نادر شیبانی nader sheibani محمد ابراهیم مینایی mohammad ebrahim minaei محمد علی عارف پور ترابی

background: recently, botulinum neurotoxin (bont)-derived recombinant proteins have been suggested as potential botulism vaccines. here, with concentrating on bont type e (bont/e), we studied two of these binding domain-based recombinant proteins: a multivalent chimer protein, which is composed of bont serotypes a, b and e binding subdomains, and a monovalent recombinant protein, which contains...

2010
Shashi K. Sharma Uma Basavanna Hem D. Shukla

Botulinum neurotoxins (BoNTs) are highly potent poisons produced by seven serotypes of Clostridium botulinum. The mechanism of neurotoxin action is a multistep process which leads to the cleavage of one of three different SNARE proteins essential for synaptic vesicle fusion and transmission of the nerve signals to muscles: synaptobrevin, syntaxin, or SNAP-25. In order to understand the precise ...

2014
Karl A. Hassan Liam D. H. Elbourne Sasha G. Tetu Eric A. Johnson Ian T. Paulsen

Clostridium strains from six phylogenetic groups, C. botulinum groups I to IV, C. baratii, and C. butyricum, display the capacity to produce botulinum neurotoxin. Here, we present the genome sequence of a C. butyricum isolate, the neurotoxigenic strain 5521, which encodes the type E botulinum neurotoxin.

Journal: :Journal of biomedical science 2000
R H Shyu M F Shaio S S Tang H F Shyu C F Lee M H Tsai J E Smith H H Huang J J Wey J L Huang H H Chang

Botulinum neurotoxin (BoNT) is one of the most toxic substances known to produce severe neuromuscular paralysis. The currently used vaccine is prepared mainly from biohazardous toxins. Thus, we studied an alternative method and demonstrated that DNA immunization provided sufficient protection against botulism in a murine model. A plasmid of pBoNT/A-Hc, which encodes the fragment C gene of type ...

Journal: :Applied and environmental microbiology 2001
M Lindström R Keto A Markkula M Nevas S Hielm H Korkeala

Botulism is diagnosed by detecting botulinum neurotoxin and Clostridium botulinum cells in the patient and in suspected food samples. In this study, a multiplex PCR assay for the detection of Clostridium botulinum types A, B, E, and F in food and fecal material was developed. The method employs four new primer pairs with equal melting temperatures, each being specific to botulinum neurotoxin ge...

Journal: :Applied and environmental microbiology 2006
Shashi K Sharma Joseph L Ferreira Brian S Eblen Richard C Whiting

An amplified enzyme-linked immunosorbent assay (ELISA) for the detection of Clostridium botulinum complex neurotoxins was evaluated for its ability to detect these toxins in food. The assay was found to be suitable for detecting type A, B, E, and F botulinum neurotoxins in a variety of food matrices representing liquids, solid, and semisolid food. Specific foods included broccoli, orange juice,...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید